Magnetic resonance spectroscopy in Alzheimer’s disease
Jonathan Graff-Radford,1 Kejal Kantarci21Department of Neurology, 2Department of Radiology, Mayo Clinic, Rochester, MN, USAAbstract: Aging is the primary risk factor for dementia. With increasing life expectancy and aging populations worldwide, dementia is becoming one of the significant public heal...
Saved in:
Main Authors: | Graff-Radford J, Kantarci K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/641a62ce47cf4e26bb4a41e7eddbcb55 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroinflammation in Alzheimer’s disease
by: Zhang FJ, et al.
Published: (2015) -
Update on the use of memantine in Alzheimer’s disease
by: Robert J van Marum
Published: (2009) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
by: Kristinsson J, et al.
Published: (2012) -
Activation of mTOR: a culprit of Alzheimer’s disease?
by: Cai Z, et al.
Published: (2015) -
Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
by: Koppel J, et al.
Published: (2014)